Genera Research Ltd
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Biotech or pharma, animal health
Genera Research Ltd., a clinical-stage biotechnology company based in Croatia, develops recombinant human Bone Morphogenetic Protein (BMP) products for tissue regeneration in orthopedic, spinal, and dental procedures. The company focuses on R&D, production of recombinant human BMP6 (rhBMP6), and clinical trials. Genera holds over 30 globally protected patents, valid until 2043. With over 300 patients included in Phase I and II trials, the company is preparing for Phase III of its proprietary OSTEOGROW portfolio for bone regeneration.
OSTEOGROW accelerates bone healing by combining rhBMP6 with the patient’s peripheral blood to create a blood clot for implantation into bone defects, thereby preventing ectopic bone formation. This approach reduces recovery time and improves quality of life. Genera’s team of experienced clinicians and scientists is committed to driving clinical and commercial success.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}